metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology One-year survival after liver transplantation in a group of geriatric patients
Información de la revista
Vol. 29. Núm. S2.
Abstracts Asociación Mexicana del Hígado (AMH) 2023
(febrero 2024)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 29. Núm. S2.
Abstracts Asociación Mexicana del Hígado (AMH) 2023
(febrero 2024)
Acceso a texto completo
One-year survival after liver transplantation in a group of geriatric patients
Visitas
95
Carlos S. Tinitana-Jumbo1, Karen A. Hernández-Bautista1, María F. Higuera-de la Tijera1, Víctor M. Paéz-Zayas1, Daniel Santana-Vargas2, Camila Montes-Castellanos1, José L. Pérez-Hernández1
1 Department of Gastroenterology and Hepatology, Hospital General de Mexico “Dr. Eduardo Liceaga” ,Mexico City, Mexico
2 Research Department, Hospital General de Mexico “Dr. Eduardo Liceaga” ,Mexico City, Mexico
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Descargar PDF
Estadísticas
Figuras (1)
Suplemento especial
Este artículo forma parte de:
Vol. 29. Núm S2

Abstracts Asociación Mexicana del Hígado (AMH) 2023

Más datos
Introduction and Objectives

Prevalence of patients with decompensated cirrhosis with requirement of liver transplantation (LT) has increased in our country. A significant percentage of patients with this condition belongs to a geriatric population, which could contraindicate LT, although trends in other countries indicate that the results of LT in geriatric patients are excellent.

To assess one-year survival of LT patients over 60 years

Materials and Patients

Retrospective, observational, and analytical study of patients over 60 years who underwent LT, evaluating survival, cold ischemia time (CIT), hot ischemia time (HIT), and donor age (DA), compared with a group of patients under 60 years who underwent LT.

We evaluated survival over time in months with a follow-up at one year of recipients under 60 years and older than 60 using the Kaplan-Meier curve and the log-rank test, with a significant alpha level <0.05.

Results

A total of 81 patients were included: 51 under (44.33 ±10.59) and 30 over 60 years (64.13 ±3.30), 31 females (38.27%) 50 males (61.72%). Etiologies of cirrhosis: alcohol intake 30.86%, autoimmune diseases 24.69%, MALFD 11%, hepatocellular carcinoma 9.88%. CIT and HIT in under and over 60 years were 313.64 ±97.69min and 29.91 ±6.14min, and 307.39 ±101.85min and 30.36 ±7.57min, respectively. DA was 35.55 ±14.33 years. Mortality rates were 11.76% (6/51) and 13.3% (4/30) in patients under and over 60 years, respectively, with a cumulative rate of 12.34% (10/81). The average survival in months was 12.27 (11.45-13.1, 95%CI) and 10.83 (9.6-12.0, 95%CI) in under and over 60 years, respectively. Comparison based on age was not statistically significant (log-rank test, Chi-square 1=0.742, p=0.389).

Conclusions

One year survival in geriatric patients after LT is equal to that of younger patients, indicating that age should not be a contraindication for LT.

Texto completo

Ethical statement

The protocol was registered and approved by the Ethics Committee. The identity of the patients is protected. Consentment was obtained.

Declaration of interests

None

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.aohep.2024.101436
No mostrar más